BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16350577)

  • 41. Prospective study of effect of androgens on serum inflammatory markers in men.
    Ng MK; Liu PY; Williams AJ; Nakhla S; Ly LP; Handelsman DJ; Celermajer DS
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1136-41. PubMed ID: 12117728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of acute biochemical castration on insulin sensitivity in healthy adult men.
    Rabiee A; Dwyer AA; Caronia LM; Hayes FJ; Yialamas MA; Andersen DK; Thomas B; Torriani M; Elahi D
    Endocr Res; 2010 May; 35(2):71-84. PubMed ID: 20408755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.
    Pöllänen P; Nikkanen V; Huhtaniemi I
    Int J Androl; 2001 Dec; 24(6):369-80. PubMed ID: 11737418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
    Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydrotestosterone treatment in men with coronary artery disease. I. Influence on sex hormones, lipid profile, insulin resistance and fibrinogen.
    Barud W; Palusiński R; Makaruk B; Hanzlik J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):241-6. PubMed ID: 15323199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
    Meikle AW; Stephenson RA; Lewis CM; Wiebke GA; Middleton RG
    Prostate; 1997 Oct; 33(2):105-11. PubMed ID: 9316651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men.
    Pospíšilová H; Vaňková M; Hill M; Meloun M; Bendlová B; Dušková M; Stárka L
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):105-11. PubMed ID: 22421634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors.
    Rattarasarn C; Leelawattana R; Soonthornpun S; Setasuban W; Thamprasit A; Lim A; Chayanunnukul W; Thamkumpee N; Daendumrongsub T
    Metabolism; 2003 Nov; 52(11):1444-7. PubMed ID: 14624404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men.
    Pasquali R; Casimirri F; De Iasio R; Mesini P; Boschi S; Chierici R; Flamia R; Biscotti M; Vicennati V
    J Clin Endocrinol Metab; 1995 Feb; 80(2):654-8. PubMed ID: 7852532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.
    Thirumalai A; Cooper LA; Rubinow KB; Amory JK; Lin DW; Wright JL; Marck BT; Matsumoto AM; Page ST
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2937-44. PubMed ID: 27172434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone secretion after testosterone administration to men with visceral obesity.
    Mårin P; Rosmond R; Bengtsson BA; Gustafsson C; Holm G; Björntorp P
    Obes Res; 1994 May; 2(3):263-70. PubMed ID: 16353427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.